Safety and Efficacy of Intravenous (IV) Dexmedetomidine During Flexible Bronchoscopy and Endobronchial Ultrasound
Withdrawn before enrolling · Phase 4
Conditions studied: Pain
In brief
To achieve safe,consistent, continuous sedation using Dexmedetomidine in advaced bronchoscopy procedures that may reduce the need for rapid pain sedative infusion.
Key facts
- Study ID
- NCT00691886
- Run by
- Lahey Clinic
- People needed
- 0
- Starts
- 2008-04-01
- Expected to finish
- 2012-07-01
- Last updated by the study team
- 2012-05-10
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults between the age of 18 and 85
- Adults scheduled for flexible brochoscopy using EUBS (Endobronchial Ultrasound)
You may not qualify if…
- Sever bradycardia (rate < 50) and / or related bradydysrhymias (e.g. advanced heart block)
- Impaired ventricular functions (EF <30%)
- Hypovolemia or hypotension (SBP <90 or MAP <a55)
- Have GFR less than 15ml/min 1.73m2 or undergoing hemodialysis
- Endstage liver disease.
Where it is running
- Lahey Clinic — Burlington, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.